Published in J Hypertens on January 01, 2003
Redox control of renal function and hypertension. Antioxid Redox Signal (2008) 1.45
Modulation of oxidative stress-induced changes in hypertension and atherosclerosis by antioxidants. Exp Clin Cardiol (2006) 0.94
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept. Cardiovasc Diabetol (2004) 0.92
Melatonin improves memory acquisition under stress independent of stress hormone release. Psychopharmacology (Berl) (2008) 0.82
Peripheral and central effects of melatonin on blood pressure regulation. Int J Mol Sci (2014) 0.81
A model of cellular cardiac-neural coupling that captures the sympathetic control of sinoatrial node excitability in normotensive and hypertensive rats. Biophys J (2011) 0.78
Dietary Sources and Bioactivities of Melatonin. Nutrients (2017) 0.75
Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease. Clin Exp Nephrol (2016) 0.75
Transgenic rescue of defective Cd36 enhances myocardial adenylyl cyclase signaling in spontaneously hypertensive rats. Pflugers Arch (2013) 0.75
Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats. J Hypertens (2002) 1.55
NAD(P)H oxidase activation by angiotensin II is dependent on p42/44 ERK-MAPK pathway activation in rat's vascular smooth muscle cells. J Hypertens (2003) 1.52
Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients. J Hypertens (2005) 1.49
Endothelin is a dose-dependent trophic factor and a mitogen in small arteries in vivo. Cardiovasc Res (2006) 1.45
Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes. J Hypertens (2005) 1.44
Contribution of endogenous endothelin in the enhanced coronary constriction in DOCA-salt hypertensive rats. J Hypertens (2003) 1.41
Comparison of the cardiovascular protection by omapatrilat and lisinopril treatments in DOCA-salt hypertension. J Hypertens (2003) 1.40
Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Am J Hypertens (2003) 1.12
Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid. Hypertension (2002) 1.11
Antioxidative properties of acetylsalicylic Acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation (2002) 0.94
The effect of 2 sympatholytic medications--propranolol and clonidine--on sleep bruxism: experimental randomized controlled studies. Sleep (2006) 0.94
Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats. Hypertension (2005) 0.94
Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart. Life Sci (2003) 0.94
Endothelin mediates superoxide production in angiotensin II-induced hypertension in rats. Free Radic Biol Med (2005) 0.94
Endocannabinoids protect the rat isolated heart against ischaemia. Br J Pharmacol (2003) 0.93
Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients. Int J Cardiol (2013) 0.90
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts. Cardiovasc Res (2002) 0.89
Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts. Life Sci (2007) 0.89
N-acetylcysteine improves nitric oxide and alpha-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats. Am J Hypertens (2003) 0.85
Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats. Am J Hypertens (2006) 0.85
Cardiac and peripheral actions of growth hormone and its releasing peptides: relevance for the treatment of cardiomyopathies. Cardiovasc Res (2005) 0.85
Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives. Am J Hypertens (2005) 0.85
Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice. Hypertension (2008) 0.84
Treatment by n-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve. Am J Hypertens (2004) 0.84
Signaling pathways involved in the cardioprotective effects of cannabinoids. J Pharmacol Sci (2006) 0.84
Role of nitric oxide and protein kinase C in the tachyphylaxis to vasopressin in rat aortic rings. Life Sci (2005) 0.83
Comparative effects of N-acetyl-L-cysteine and ramipril on arterial hypertension, insulin resistance, and oxidative stress in chronically glucose-fed rats. Can J Physiol Pharmacol (2008) 0.82
Does atorvastatin induce aortic smooth muscle cell apoptosis in vivo? Vascul Pharmacol (2010) 0.82
Randomized controlled trial on the long-term efficacy of a multifaceted, interdisciplinary lifestyle intervention in reducing cardiovascular risk and improving lifestyle in patients at risk of cardiovascular disease. J Behav Med (2012) 0.81
Increases of spinal kinin receptor binding sites in two rat models of insulin resistance. Peptides (2005) 0.81
A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension. Blood Press Monit (2004) 0.80
Rescue of amitriptyline-intoxicated hearts with nanosized vesicles. Cardiovasc Res (2007) 0.80
The interrelation of the angiotensin and endothelin systems on the modulation of NAD(P)H oxidase. Can J Physiol Pharmacol (2006) 0.79
Does QTc interval predict the response to beta-blockers and calcium channel blockers in hypertensives? Heart Dis (2003) 0.78
Is there a role for reactive oxygen species in arterial medial elastocalcinosis? Vascul Pharmacol (2006) 0.78
Acute and chronic effects of free radicals on alpha1-adrenergic-induced vasoconstriction in mesenteric beds of spontaneously hypertensive rats. J Hypertens (2005) 0.78
A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart. Int Immunopharmacol (2003) 0.78
Effects of alpha-lipoic acid on kinin B1 and B2 receptor binding sites in the spinal cord of chronically angiotensin-treated rats. Peptides (2005) 0.78
Inhibitory effect of melatonin on alpha1-adrenergic-induced vasoconstriction in mesenteric beds of spontaneously hypertensive rats. Am J Hypertens (2004) 0.77
Protective effects of aspirin from cardiac hypertrophy and oxidative stress in cardiomyopathic hamsters. Oxid Med Cell Longev (2012) 0.75
Bradykinin metabolism in rat hearts with left-ventricular hypertrophy following myocardial infarction. Can J Physiol Pharmacol (2003) 0.75
The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides. Can J Physiol Pharmacol (2005) 0.75
[Role of cyclo-oxygenases in the effects of angiotensin II]. Med Sci (Paris) (2006) 0.75